STEPHANIE CAUDILL: Open Payments
NPI 1104431543 · WINCHESTER, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$195 in 9 payments from 6 companies in 2025. Trend: 2023 $397 · 2024 $125 · 2025 $195
Food & beverage: $195
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Gilead Sciences, Inc. | 1 | $25 |
| Indivior Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: CAPLYTA, VIVITROL, ARISTADA, SUBLOCADE, REXULTI, INGREZZA.
Industry payments across KY — which companies pay providers there.
